Cargando…
Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis: An Updated Meta-Analysis
BACKGROUND/AIMS: Somatostatin is regarded as a prophylactic agent on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), but studies are still controversial. MATERIALS AND METHODS: Electronic databases, including PubMed, EMBASE, the Cochrane library, and the Science Citati...
Autores principales: | Qin, Xie, Lei, Wen S., Xing, Zhang X., Shi, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707805/ https://www.ncbi.nlm.nih.gov/pubmed/26655132 http://dx.doi.org/10.4103/1319-3767.167187 |
Ejemplares similares
-
Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis
por: Hu, Jing, et al.
Publicado: (2016) -
Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
por: Zheng, Minghua, et al.
Publicado: (2008) -
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021) -
Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients
por: ZHAO, LI-NA, et al.
Publicado: (2014) -
Prevention of Post-ERCP Pancreatitis
por: Donnellan, F., et al.
Publicado: (2012)